Germany mulls state cannabis body for pain relief

Warning message

The subscription service is currently unavailable. Please try again later.

Germany's government has plans to set up a pharmaceutical agency to regulate the cultivation of cannabis for medicinal purposes, according to a media report. Such a step could make the drug more accessible to ill people.

A so-called cannabis agency has been proposed in draft legislation put forward by the federal health ministry, the "Welt am Sonntag" newspaper reported on Sunday.

The bill was reportedly awaiting approval from the office of Chancellor Angela Merkel. As outlined in the draft, the new state-owned body would be tasked with regulating the price of medicinal hemp and making sure the drug was grown and sold purely for pharmaceutical purposes. Patients in need of pain relief would not be allowed to grow their own cannabis plants.

The drug can stimulate the appetite and treat nausea, and its two main active ingredients - tetrahydrocannabinol and cannabidiol - have powerful analgesic and antispasmodic effects. Germany has...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.